1. Home
  2. ASMB vs ACOG Comparison

ASMB vs ACOG Comparison

Compare ASMB & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • ACOG
  • Stock Information
  • Founded
  • ASMB 2005
  • ACOG 2000
  • Country
  • ASMB United States
  • ACOG Canada
  • Employees
  • ASMB N/A
  • ACOG N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • ACOG
  • Sector
  • ASMB Health Care
  • ACOG
  • Exchange
  • ASMB Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • ASMB 84.5M
  • ACOG 91.6M
  • IPO Year
  • ASMB 2010
  • ACOG N/A
  • Fundamental
  • Price
  • ASMB $10.03
  • ACOG $4.12
  • Analyst Decision
  • ASMB Strong Buy
  • ACOG Strong Buy
  • Analyst Count
  • ASMB 3
  • ACOG 1
  • Target Price
  • ASMB $33.00
  • ACOG $20.00
  • AVG Volume (30 Days)
  • ASMB 37.9K
  • ACOG 75.4K
  • Earning Date
  • ASMB 05-07-2025
  • ACOG 05-20-2025
  • Dividend Yield
  • ASMB N/A
  • ACOG N/A
  • EPS Growth
  • ASMB N/A
  • ACOG N/A
  • EPS
  • ASMB N/A
  • ACOG N/A
  • Revenue
  • ASMB $28,520,000.00
  • ACOG N/A
  • Revenue This Year
  • ASMB $10.82
  • ACOG N/A
  • Revenue Next Year
  • ASMB N/A
  • ACOG N/A
  • P/E Ratio
  • ASMB N/A
  • ACOG N/A
  • Revenue Growth
  • ASMB 298.16
  • ACOG N/A
  • 52 Week Low
  • ASMB $7.75
  • ACOG $3.75
  • 52 Week High
  • ASMB $19.93
  • ACOG $7.00
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 48.99
  • ACOG N/A
  • Support Level
  • ASMB $7.90
  • ACOG N/A
  • Resistance Level
  • ASMB $10.36
  • ACOG N/A
  • Average True Range (ATR)
  • ASMB 0.85
  • ACOG 0.00
  • MACD
  • ASMB 0.21
  • ACOG 0.00
  • Stochastic Oscillator
  • ASMB 86.04
  • ACOG 0.00

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.

Share on Social Networks: